Engage Therapeutics would never have been founded if it weren’t for the encouragement and support of organizations that have been working on epilepsy issues for many years.
We are proud to collaborate with many individuals and organizations who are committed to making a difference through education, research, and fundraising initiatives focused on improving life for those impacted by epilepsy.
We encourage you to learn more about these exceptional organizations and the important work in which they are engaged.
Find Us On Our Partner Sites
- A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects with Epilepsy with a Predictable Seizure Pattern
- Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern (StATES)
- Engage Therapeutics Doses First Patient In Phase 2b Trial Of Epilepsy Seizure Rescue Therapy Staccato® Alprazolam
- 2018 F.A.C.E.S. Annual Newsletter (A FACES-Inspired Clinical Trial to Investigate the Efficacy and Clinical Usability of Staccato Alprazolam (STAP-001) in Those with Epilepsy with a Predictable Seizure Pattern p.16)
Please note that these are third party websites, and Engage Therapeutics does not create or monitor the additional content on these pages.